Skip to main content
Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
2.130
+0.070 (3.40%)
At close: Jun 26, 2026, 4:00 PM EDT
2.130
0.00 (-0.01%)
After-hours: Jun 26, 2026, 7:54 PM EDT

Allogene Therapeutics Employees

As of December 31, 2025, Allogene Therapeutics had 152 total employees, including 150 full-time and 2 part-time employees. The number of employees decreased by 77 or -33.62% compared to the previous year.

Employees
152
Change (1Y)
-77
Growth (1Y)
-33.62%
Revenue / Employee
n/a
Profits / Employee
-$1,143,158
Market Cap
735.18M

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 2025152-77-33.62%
Dec 31, 2024229-4-1.72%
Dec 31, 2023233-128-35.46%
Dec 31, 20223615116.45%
Dec 31, 20213104516.98%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Related Stocks

Company Name Employees
Rigel Pharmaceuticals 174
Inventiva 77
Aclaris Therapeutics 73
CytomX Therapeutics 69
Oculis Holding AG 60
Candel Therapeutics 55
Climb Bio 29
Immix Biopharma 21
Employee Rankings

ALLO News

More News